NCT01509209
Source recordAI-normalized
Efficacy and Safety of Cossac L Tablet in Vasomotor Rhinitis Patients : A Randomized, Double-blind, Placebo-controlled, Phase 3 Clinical Trial
The purpose of this study is to evaluate efficacy and safety of Cossac L tablet in the treatment of vasomotor rhinitis
AI analysis
Indication: Vasomotor Rhinitis
Modality: small molecule
Target: Pseudoephedrine / Levocetirizine
Sponsor: Hanmi Pharmaceutical Company Limited
Source URL: ClinicalTrials.gov
Source updated: May 23, 2013
Ingested: Jun 11, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Pseudoephedrine / Levocetirizine
View original source fields
Condition raw: Vasomotor Rhinitis
Condition normalized: Vasomotor Rhinitis
Modality raw: small molecule
Modality normalized: small molecule
Target raw: Pseudoephedrine / Levocetirizine
Target normalized: Pseudoephedrine / Levocetirizine